Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 11-May 2022. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1919491000001119 | Dostarlimab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1919501000001111 | Dostarlimab (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dostarlimab | Is a | Substance with programmed cell death protein 1 inhibitor mechanism of action (substance) | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Dostarlimab 500mg/10ml solution for infusion vials | Has specific active ingredient | False | Dostarlimab | Inferred relationship | Existential restriction modifier | |
| Jemperli 500mg/10ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) 1 vial | Has specific active ingredient | False | Dostarlimab | Inferred relationship | Existential restriction modifier | |
| Dostarlimab 500mg/10ml solution for infusion vials 1 vial | Has specific active ingredient | False | Dostarlimab | Inferred relationship | Existential restriction modifier | |
| Jemperli 500mg/10ml concentrate for solution for infusion vials (GlaxoSmithKline UK Ltd) | Has specific active ingredient | False | Dostarlimab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR